Shemirani Hasan, Tajmirriahi Marzieh, Nikneshan Ali, Kleidari Behrooz
Professor, Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Assistant Professor, Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
ARYA Atheroscler. 2021 Jul;17(4):1-6. doi: 10.22122/arya.v17i0.2251.
It has been proposed that left ventricular diastolic dysfunction (LVDD) is a possible physiological link between high body mass index (BMI) and future occurrence of heart failure (HF). The present cross-sectional study was aimed to analyze the association between BMI and LVDD by transthoracic echocardiography (TTE).
This study was conducted from May 2017 to September 2019 in Khorshid Hospital of Isfahan University of Medical Sciences, Isfahan, Iran. Based on the calculated BMI (kg/m²), patients were divided into three groups: group 1: subjects with BMI < 25, as a normal group (n = 75), group 2: volunteer cases with 40 > BMI ≥ 30, as an obese group (n = 98), and group 3: patients with BMI ≥ 40, as a morbidly obese group (n = 100). TTE was performed by a trained cardiologist and associated variables including left atrium (LA) volume, E, septal e', lateral e', and E/e' were assessed and also subjects were characterized as normal diastolic function, abnormal diastolic function, and inconclusive diagnosis of diastolic dysfunction (DD).
Apart from the ejection fraction (EF) and the tricuspid regurgitation velocity (TRV), there was a significant difference between the other echocardiographic variables including LA volume, E, septal e', lateral e', and E/e' (P < 0.05). One patient with morbid obesity in our study revealed LVDD. There was no significant difference between three groups (P = 0.42).
There is no considerable relationship between obesity and LVDD. It seems that the absence of associated comorbidities such as diabetes, coronary disorders, etc. plays a crucial role in preventing LVDD, but for realistic and definitive decision, more cellular and molecular investigations and studies with larger sample size are necessary.
有人提出左心室舒张功能障碍(LVDD)可能是高体重指数(BMI)与未来心力衰竭(HF)发生之间的生理联系。本横断面研究旨在通过经胸超声心动图(TTE)分析BMI与LVDD之间的关联。
本研究于2017年5月至2019年9月在伊朗伊斯法罕医科大学霍希德医院进行。根据计算出的BMI(kg/m²),患者分为三组:第1组:BMI<25的受试者,作为正常组(n = 75);第2组:BMI≥30且BMI<40的志愿者病例,作为肥胖组(n = 98);第3组:BMI≥40的患者,作为病态肥胖组(n = 100)。由训练有素的心脏病专家进行TTE检查,并评估包括左心房(LA)容积、E、室间隔e'、侧壁e'和E/e'等相关变量,同时将受试者分为舒张功能正常、舒张功能异常和舒张功能障碍(DD)诊断不确定三类。
除射血分数(EF)和三尖瓣反流速度(TRV)外,包括LA容积、E、室间隔e'、侧壁e'和E/e'在内的其他超声心动图变量之间存在显著差异(P<0.05)。我们研究中的一名病态肥胖患者出现了LVDD。三组之间无显著差异(P = 0.42)。
肥胖与LVDD之间没有显著关系。似乎没有糖尿病、冠状动脉疾病等相关合并症在预防LVDD中起关键作用,但要做出实际和明确的决定,需要进行更多的细胞和分子研究以及更大样本量的研究。